These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29889676)

  • 1. Single-Dose Rivaroxaban-Induced Acute Liver Injury.
    Verheyen E; Kileci JA; Mathew JP
    Am J Ther; 2019; 26(4):e538-e540. PubMed ID: 29889676
    [No Abstract]   [Full Text] [Related]  

  • 2. Rivaroxaban: liver injury.
    Prescrire Int; 2015 Nov; 24(165):268. PubMed ID: 26688900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rivaroxaban for post-discharge thromboprophylaxis: the MARINER trial.
    Ramacciotti E; Fareed J
    Int Angiol; 2018 Dec; 37(6):427-430. PubMed ID: 30558402
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver injury during rivaroxaban treatment in a patient with AL amyloidosis.
    Marrinan A; Shackleton L; Kelly C; Lavin M; Glavey S; Murphy P; Quinn J
    Eur J Clin Pharmacol; 2021 Jul; 77(7):1073-1076. PubMed ID: 33427957
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nosebleed in new oral anticoagulant treatment - what should be done?].
    Stiefelhagen P
    MMW Fortschr Med; 2015 Sep; 157(15):25. PubMed ID: 26349711
    [No Abstract]   [Full Text] [Related]  

  • 6. Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases.
    Licata A; Puccia F; Lombardo V; Serruto A; Minissale MG; Morreale I; Giannitrapani L; Soresi M; Montalto G; Almasio PL
    Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):226-232. PubMed ID: 29120909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rivaroxaban-induced liver injury: Results from a venous thromboembolism registry.
    Lambert A; Cordeanu M; Gaertner S; Nouri S; Alt M; Stephan D
    Int J Cardiol; 2015 Jul; 191():265-6. PubMed ID: 25981364
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pruritus and rivaroxaban].
    Aguilar-Shea AL; Gallardo-Mayo C
    Semergen; 2018; 44(4):e96-e97. PubMed ID: 29439912
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe drug-induced skin and liver injury from rivaroxaban.
    Barrett P; Vuppalanchi R; Masuoka H; Chalasani N
    Dig Dis Sci; 2015 Jun; 60(6):1856-8. PubMed ID: 25559757
    [No Abstract]   [Full Text] [Related]  

  • 10. Bleeding associated with coadministration of rivaroxaban and clarithromycin.
    Fralick M; Juurlink DN; Marras T
    CMAJ; 2016 Jun; 188(9):669-672. PubMed ID: 26811362
    [No Abstract]   [Full Text] [Related]  

  • 11. "Bite-sized" rivaroxaban patient education and its effect on knowledge.
    Sedlacek J; Giuliano CA; Baisden K; Lipari M
    Int J Clin Pharm; 2019 Feb; 41(1):6-8. PubMed ID: 30515711
    [No Abstract]   [Full Text] [Related]  

  • 12. Orthotopic Liver Transplant in a Patient Anticoagulated With Rivaroxaban: A Case Report.
    Vuilleumier PH; Nagler M; Beldi G; Vogt A
    A A Pract; 2019 Jul; 13(2):54-57. PubMed ID: 30829681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral adrenal gland hemorrhage in a patient treated with rivaroxaban.
    Comuth W; Christiansen JJ; Bloch-Münster AM; Husted S
    Blood Coagul Fibrinolysis; 2017 Jan; 28(1):102-104. PubMed ID: 26919451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute liver failure following atorvastatin dose escalation: is there a threshold dose for idiosyncratic hepatotoxicity?
    Carrascosa MF; Salcines-Caviedes JR; Lucena MI; Andrade RJ
    J Hepatol; 2015 Mar; 62(3):751-2. PubMed ID: 25463547
    [No Abstract]   [Full Text] [Related]  

  • 15. New oral anticoagulants (NOAC) and liver injury.
    Moore N; Blin P; Gulmez SE
    J Hepatol; 2014 Aug; 61(2):198-9. PubMed ID: 24837361
    [No Abstract]   [Full Text] [Related]  

  • 16. Rivaroxaban in peripheral artery disease: The new kid on the block?
    Hussain MA; Verma S; Al-Omran M
    J Vasc Surg; 2018 Mar; 67(3):985-986. PubMed ID: 29477208
    [No Abstract]   [Full Text] [Related]  

  • 17. Rivaroxaban postmarketing risk of liver injury.
    Russmann S; Niedrig DF; Budmiger M; Schmidt C; Stieger B; Hürlimann S; Kullak-Ublick GA
    J Hepatol; 2014 Aug; 61(2):293-300. PubMed ID: 24681117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Greenlight™ photovaporization of the prostate in patients under rivaroxaban: Lesson learned after the first cases.
    Charbonneau H; Pathak A; Albenque JP; Misrai V
    Prog Urol; 2016 Apr; 26(5):273-5. PubMed ID: 26970929
    [No Abstract]   [Full Text] [Related]  

  • 19. A Case Report of Henoch-Schonlein Purpura and IgA Nephropathy Associated With Rivaroxaban.
    Chung EY; Chen J; Roxburgh S
    Nephrology (Carlton); 2018 Mar; 23(3):289-290. PubMed ID: 29461002
    [No Abstract]   [Full Text] [Related]  

  • 20. Rivaroxaban (Xarelto) - a new peripheral artery disease indication.
    Med Lett Drugs Ther; 2021 Nov; 63(1636):172-173. PubMed ID: 35085206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.